White Paper
Using AI & Machine Learning to Drive Commercial Success in the EU
How pharma can harness AI & machine learning to analyze vast customer data sets while still adhering to data privacy laws
Mar 29, 2019
Download

Artificial intelligence (AI) and machine learning are already transforming the sales and marketing process in the EU’s healthcare landscape. Companies that don’t get on board soon risk losing market share and annoying customers.

Healthcare industry sales and marketing teams in the EU have little time to capture the attention of the prescribers and customers who use their products. They have to make rapid decisions about their marketing and sales efforts. But without clear data about the impact those decisions have on prescriptions, they’ve had to rely on instinct and personal experience to customize their approach. At the same time, the healthcare industry is becoming more competitive and dynamic. Teams need access to deeper market insights to craft data driven strategies and implement their efforts with speed and precision.

Advances in AI & machine learning, combined with healthcare data from pharmacies, insurers, healthcare professionals (HCP), labs, marketing campaigns, and social media, can provide them with that competitive edge.

Healthcare companies that integrate AI & machine learning into their sales and marketing strategies can replace gut instinct with evidence-based insights that predict complex patterns in prescribing and sales behavior. These technologies make it possible to quantify physician potential and attitudes, optimize multichannel marketing (MCM), run brand diagnostics, and to profile, target and segment HCPs.

Highlights include:

  • Selecting the right data and push the limits of data integration
  • Navigate the variable regulatory landscapes
  • Develop game-changing insights and competitive advantage on both a global and local scale

Download the white paper and learn how it’s happening now!

 

DOWNLOAD TO READ MORE

Related solutions

Contact Us